Comparison between immunotherapy efficacy in early non-small cell lung cancer and advanced non-small cell lung cancer: a systematic review

BACKGROUND: Currently, immunotherapy is widely used in the treatment of various stages of non-small cell lung cancer. According to clinical experience and results of previous studies, immunotherapy as neoadjuvant therapy seems to exhibit better efficacy against early resectable non-small cell lung c...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yimin, Li, Chuling, Wang, Zimu, Wang, Zhaofeng, Wu, Ranpu, Wu, Ying, Song, Yong, Liu, Hongbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641944/
https://www.ncbi.nlm.nih.gov/pubmed/36345004
http://dx.doi.org/10.1186/s12916-022-02580-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641944/
https://www.ncbi.nlm.nih.gov/pubmed/36345004
http://dx.doi.org/10.1186/s12916-022-02580-1

Ejemplares similares